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Diabetes, hypertension and hypercholesterolemia are established risk factors associated 
with the development of atherosclerosis and cardiovascular disease (CVD) including 
myocardial infarction (MI) and stroke.  Recently, a family history of adverse 
cardiovascular events has also been recognised as a significant independent risk factor.  
Despite evidence that 40 to 60 % of coronary artery disease (CAD) and myocardial 
infarction (MI) are associated with genetic heritability, the genetic basis of these diseases 
is not fully resolved [1,2]. Mendelian forms of hypertension and hypercholesterolemia 
have been well characterised [3,4].  Most of our knowledge of lipoprotein genetics stems 
from monogenic familial disorders of lipoprotein metabolism with extreme phenotypes 
e.g. familial hypercholesterolemia is characterised by highly elevated serum levels of 
LDL-C [4].  Genome-wide linkage studies have reliably identified genes responsible for 
these conditions, however, they constitute only a minor proportion of total lipoprotein 
disorders.  New approaches to determine which common genetic variants may be 
responsible for lipid disorders within the wider population have concentrated on the 
association between clinical phenotype and single nucleotide polymorphisms (SNPs) or 
genetic loci in multiple genes known to influence risk factors [5,6.].  These systematic 
genome-wide association studies (GWAS) have identified several new loci [7,8].   
 
Blood lipid levels are genetic phenotypes and are influenced by multiple genetic and 
environmental factors.  Heritability for LDL-C, HDL-C and triglycerides is estimated to 
be in the region of 50 % [5].  Examples of sequence variants in individual genes linked 
to blood lipid phenotypes include APOE/PCSK9 with LDL-C, CETP/LIPC/LPL with 
HDL-C, and APOA5 with triglycerides.  Much of this data has been derived from cohorts 
of white individuals of European ancestry.  A new study by Keebler et al. [9..] is the 
first to investigate whether newly identified single-nucleotide polymorphisms (SNP) 
from GWA studies at 19 loci associated with blood lipids in individuals of European 
origin are also found in subjects of different ethnicities.  Participants were from the 
National Health and Nutrition Examination Survey (NHANES) III cohort.  Following 
exclusion for missing phenotype, age below 18 years and those on lipid-lowering drugs 
the group comprised 1627 non-Hispanic blacks, 1659 Mexican Americans and 2230 non-
Hispanic whites.  Blood levels of HDL-C and triglycerides were measured using standard 
enzymatic techniques,  LDL-C was calculated using the Friedwald formula. DNA was 
isolated from cell lines derived from blood samples.  Genotyping was carried out on the 
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Sequenom platform.  Ethnic-specific blood lipid levels were determined adjusting for age 
and gender and ethnic-specific linear regression was used to examine the association of 
genotype with blood lipids.  A fixed-effects variance-weighted meta analysis was used 
WRVXPPDULVHWKHVWDWLVWLFDOGDWD3IRUWKHVDPHDOOHOHDWWKHVDme SNP for the 
same trait described in the original reports was deemed significant.  At 5 loci the same 
SNP identified in whites was found to be significantly associated with blood lipids across 
all ethnic groups.  At 1p13 near PSRC1/CELSR2/SORT1, rs646776 and at HMGCR, 
rs12654264 were associated with LDL-C.  In all groups each copy of the minor G allele 
in polymorphism rs646776 lowered LDL-C.  SNPs, r1800775 at CETP and rs328 at LPL 
were associated with HDL-C.  Increases in minor allele copy number of r1800775 and 
rs328 resulted in decreases and increases in HDL-C respectively.  At APOA5, an increase 
in minor allele copy number of rs3135506 was associated with increases in triglyceride 
levels.  Variable results at the remaining loci suggest more work is required to study each 
locus in blacks and Mexican Americans.  These data indicate that all 5 loci are important 
for controlling lipid profiles across ethnic/racial groups and highlight the relevance of 
the newly discovered locus at 1p13 near PSRC1/CELSR2/SORT1. This locus could be 
pivotally important in dyslipidaemias with phenotypic consequences in disease 
processes.  
 
GWA studies have identified common variants in the fat mass and obesity (FTO) gene 
associated with body mass index (BMI) and increased risk of obesity [10,11].  Increases 
in body fat are well acknowledged to increase the risk of insulin resistant type 2 diabetes 
(T2D) and CVD.  In a recent study Doney et al., [12.]  examined the clinical impact of 
genetic variation of SNP rs9939609 in FTO at 16q10 on the risk of MI in 4897 patients 
with T2D from the prospective Genetics and Diabetes Audit and Research Study in 
Tayside Scotland (Go-Darts) Study. The rs9939609 A allele was found to be associated 
with increased BMI, lower plasma HDL-C levels, higher plasma triglycerides, greater 
atherogenic index of plasma and increased risk of MI during follow-up (mean 3.6 years) 
compared to TT homozygotes.  Interestingly increased risk of MI was observed only in 
nonstatin users (predominantly TT homozygotes) and was abolished by statin use 
(predominantly carriers of the A allele) suggesting FTO genotype may provide  a 
therapeutic target. 
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The FTO rs9939609 A allele was shown to be associated with low HDL-C and high 
plasma triglyceride levels and increased risk of MI. Statins reduced deaths 
suggesting the FTO genotype may provide a therapeutic target. 
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 Oestrogen protects against CVD and acts by binding to receptors.  Two types of 
receptor, have been identified, a G-protein coupled receptor and a ligand binding 
nuclear receptor or transcription factor (ER).  ER exists in two forms, D and E 
encoded by different genes ESR1 (6q25.1) and ESR2 (14q).  This study confirms that 
2 SNP, PvuII (rs2234693) and Xbal (rs9340799) of ESR1, previously identified in 
Western populations, are also associated with increased risk of hyperlipidemia in 
Chinese postmeopausal women.  Risk was independent of age, estradiol levels. BMI 
and lifestyle. 
 
